Your browser doesn't support javascript.
loading
Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer.
Suzuki, C; Kiyota, N; Imamura, Y; Rikitake, J; Sai, S; Koyama, T; Hyogo, Y; Nagatani, Y; Funakoshi, Y; Toyoda, M; Otsuki, N; Nibu, K I; Minami, H.
Afiliación
  • Suzuki C; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Kiyota N; Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Imamura Y; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan. nkiyota@med.kobe-u.ac.jp.
  • Rikitake J; Cancer Center, Kobe University Hospital, 7-5-1, Kusunokicho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. nkiyota@med.kobe-u.ac.jp.
  • Sai S; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Koyama T; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Hyogo Y; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Nagatani Y; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Funakoshi Y; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Toyoda M; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Otsuki N; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Nibu KI; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Minami H; Department of Otolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Int J Clin Oncol ; 25(7): 1270-1277, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32277393

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Carcinoma de Células Escamosas de Cabeza y Cuello / Nivolumab / Neoplasias de Cabeza y Cuello Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Carcinoma de Células Escamosas de Cabeza y Cuello / Nivolumab / Neoplasias de Cabeza y Cuello Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón